Roy Doumani serves as Executive at Kite Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Roy Doumani has executed 16 insider transactions totaling $3.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 3, 2017 involved selling 1,807 shares valued at $0.
Roy Doumani currently holds 1,807 shares of Kite Pharma, Inc. (KITE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roy Doumani has been a net seller of KITE stock. They have purchased $0 and sold $3.5M worth of shares.
Roy Doumani's most recent insider trade was on Oct 3, 2017, when they sold 1,807 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $180.00 |
| Discretionary |
| Oct 3, 2017 | KITE | $27.1M | Tender | 150,620 | $180.00 | Discretionary |
| Jun 20, 2017 | KITE | $0 | Award | 2,410 | $N/A | Discretionary |
| Jun 8, 2017 | KITE | $422.6K | Sale | 5,000 | $84.53 | Discretionary |
| Jun 7, 2017 | KITE | $844.6K | Sale | 10,000 | $84.46 | Discretionary |
| Mar 1, 2017 | KITE | $462.2K | Sale | 6,000 | $77.03 | Discretionary |
| Mar 1, 2017 | KITE | $67.5K | Option Exercise | 50,000 | $1.35 | Discretionary |
| Mar 1, 2017 | KITE | $215.0K | Sale | 2,800 | $76.77 | Discretionary |
| Mar 1, 2017 | KITE | $722.7K | Sale | 10,000 | $72.27 | Discretionary |
| Jun 6, 2016 | KITE | $233.5K | Sale | 4,000 | $58.38 | Discretionary |
| Jun 6, 2016 | KITE | $287.8K | Sale | 5,000 | $57.56 | Discretionary |
| Jun 6, 2016 | KITE | $291.3K | Sale | 5,000 | $58.25 | Discretionary |
| Jun 1, 2016 | KITE | $0 | Award | 1,950 | $N/A | Discretionary |
| Jun 25, 2014 | KITE | $0 | Conversion | 31,865 | $N/A | Discretionary |
| Jun 25, 2014 | KITE | $0 | Conversion | 139,067 | $N/A | Discretionary |